Haleon plc (HLN)Healthcare | Drug Manufacturers - Specialty & Generic | Weybridge, United Kingdom | NYSE
9.75 USD
+0.16
(1.668%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 9.66 -0.09 (-0.090%) ⇩ (April 17, 2026, 7:58 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★★★☆ | Dividends: ★★★★★ |
Hot Take | April 19, 2026, 12:36 a.m. EDT
Haleon (HLN) is a high-yield anchor (nearly 2% yield) with solid long-term fundamentals (low PE, consistent growth), making it a strong buy for portfolio stability. However, the stock has sold off sharply on recent revenue misses, and the options market is aggressively pricing in further near-term weakness via heavy put flow. This creates a divergent view: a strategic accumulation zone for the long hold, but a defensive, short-term bias against the immediate catalyst until the next earnings stabilization. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.040279 |
| AutoARIMA | 0.040319 |
| MSTL | 0.041382 |
| AutoTheta | 0.043838 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 77% |
| H-stat | 1.07 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.177 |
| Excess Kurtosis | -1.21 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2026-04-09 |
| Last Dividend Date | 2026-04-09 |
| Debt to Equity Ratio | 52.372 |
| Revenue per Share | 2.456 |
| Market Cap | 43,417,145,344 |
| Trailing P/E | 19.50 |
| Forward P/E | 16.06 |
| Beta | 0.33 |
| Profit Margins | 15.11% |
| Website | https://www.haleon.com |
As of April 19, 2026, 12:36 a.m. EDT: Speculators are aggressively betting short-term downside for the April 17 expiration, evidenced by heavy put volume (Vol 20) at the ATM strike of $10.00, effectively act as a 'new flow' hedge against the recent 7.7% drop. In contrast, callers are deeply back-tested (In-The-Money) with zero open interest on OTM strikes, indicating a lack of bullish conviction. However, for May 15 and beyond, sentiment shifts to aggressive ATM support (Calls: Vol 8, Puts: Vol 10) with negligible OTM interest, suggesting a range-bound or slightly bearish expectation for the medium term. The high implied volatility on the $7.50 puts for the near term signals significant fear pricing in, while the scarcity of OTM call volume suggests caution on upside breakouts.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 1.33% | 3.12% | 1.86% | — |
| Date | Dividend | Yield % |
|---|---|---|
| 2026-04-10 | 0.131 | 1.331301 |
| 2025-08-15 | 0.059 | 0.619506 |
| 2025-04-25 | 0.117 | 1.171679 |
| 2024-08-16 | 0.051 | 0.543278 |
| 2024-03-14 | 0.106 | 1.335056 |
| 2023-08-24 | 0.046 | 0.584472 |
| 2023-03-16 | 0.058 | 0.765103 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.04317957 |
| Address1 | The Heights |
| Address2 | Building 5, First Floor |
| All Time High | 11.42 |
| All Time Low | 5.59 |
| Ask | 9.93 |
| Ask Size | 13,300 |
| Average Analyst Rating | 2.2 - Buy |
| Average Daily Volume10 Day | 6,505,610 |
| Average Daily Volume3 Month | 8,337,966 |
| Average Volume | 8,337,966 |
| Average Volume10Days | 6,505,610 |
| Beta | 0.326 |
| Bid | 8.61 |
| Bid Size | 55,000 |
| Book Value | 4.9872823 |
| City | Weybridge |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United Kingdom |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 9.75 |
| Current Ratio | 0.922 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 9.83 |
| Day Low | 9.73 |
| Debt To Equity | 52.372 |
| Display Name | Haleon |
| Dividend Date | 1,778,716,800 |
| Dividend Rate | 0.19 |
| Dividend Yield | 1.95 |
| Earnings Call Timestamp End | 1,772,009,100 |
| Earnings Call Timestamp Start | 1,772,009,100 |
| Earnings Growth | 0.92 |
| Earnings Quarterly Growth | 0.864 |
| Earnings Timestamp | 1,772,026,200 |
| Earnings Timestamp End | 1,772,026,200 |
| Earnings Timestamp Start | 1,772,026,200 |
| Ebitda | 2,743,000,064 |
| Ebitda Margins | 0.24869 |
| Enterprise To Ebitda | 34.342 |
| Enterprise To Revenue | 8.54 |
| Enterprise Value | 94,198,751,232 |
| Eps Current Year | 0.55602 |
| Eps Forward | 0.60703 |
| Eps Trailing Twelve Months | 0.5 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,775,779,200 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.3656 |
| Fifty Day Average Change | -0.61559963 |
| Fifty Day Average Change Percent | -0.059388716 |
| Fifty Two Week Change Percent | -4.317957 |
| Fifty Two Week High | 11.42 |
| Fifty Two Week High Change | -1.6700001 |
| Fifty Two Week High Change Percent | -0.14623468 |
| Fifty Two Week Low | 8.71 |
| Fifty Two Week Low Change | 1.04 |
| Fifty Two Week Low Change Percent | 0.11940298 |
| Fifty Two Week Range | 8.71 - 11.42 |
| Financial Currency | GBP |
| First Trade Date Milliseconds | 1,658,755,800,000 |
| Float Shares | 8,857,784,880 |
| Forward Eps | 0.60703 |
| Forward P E | 16.06181 |
| Free Cashflow | 1,399,500,032 |
| Full Exchange Name | NYSE |
| Full Time Employees | 24,535 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.64769 |
| Gross Profits | 7,144,000,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00014 |
| Held Percent Institutions | 0.12727 |
| Implied Shares Outstanding | 4,453,040,815 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Dividend Date | 1,775,779,200 |
| Last Dividend Value | 0.131 |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom. |
| Long Name | Haleon plc |
| Market | us_market |
| Market Cap | 43,417,145,344 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1671690919 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 1,667,000,064 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 43,195,047,587 |
| Number Of Analyst Opinions | 5 |
| Open | 9.76 |
| Operating Cashflow | 2,633,999,872 |
| Operating Margins | 0.23171 |
| Payout Ratio | 0.37080002 |
| Peg Ratio | 2.53 |
| Phone | 44 1932 959 500 |
| Post Market Change | -0.09000015 |
| Post Market Change Percent | -0.9230785 |
| Post Market Price | 9.66 |
| Post Market Time | 1,776,470,292 |
| Previous Close | 9.59 |
| Price Eps Current Year | 17.53534 |
| Price Hint | 2 |
| Price To Book | 1.9549725 |
| Price To Sales Trailing12 Months | 3.936278 |
| Profit Margins | 0.15113 |
| Quick Ratio | 0.677 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.2 |
| Region | US |
| Regular Market Change | 0.16 |
| Regular Market Change Percent | 1.6684 |
| Regular Market Day High | 9.83 |
| Regular Market Day Low | 9.73 |
| Regular Market Day Range | 9.73 - 9.83 |
| Regular Market Open | 9.76 |
| Regular Market Previous Close | 9.59 |
| Regular Market Price | 9.75 |
| Regular Market Time | 1,776,456,002 |
| Regular Market Volume | 6,233,266 |
| Return On Assets | 0.04674 |
| Return On Equity | 0.10273 |
| Revenue Growth | 0.006 |
| Revenue Per Share | 2.456 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,453,040,815 |
| Shares Percent Shares Out | 0.0043 |
| Shares Short | 19,282,381 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 17,021,222 |
| Short Name | Haleon plc |
| Short Percent Of Float | 0.0043 |
| Short Ratio | 2.14 |
| Source Interval | 15 |
| Symbol | HLN |
| Target High Price | 13.92 |
| Target Low Price | 10.0 |
| Target Mean Price | 11.814 |
| Target Median Price | 11.85 |
| Total Cash | 1,350,000,000 |
| Total Cash Per Share | 0.152 |
| Total Debt | 8,632,999,936 |
| Total Revenue | 11,029,999,616 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.071 |
| Trailing Annual Dividend Yield | 0.0074035455 |
| Trailing Eps | 0.5 |
| Trailing P E | 19.5 |
| Trailing Peg Ratio | 2.5324 |
| Triggerable | 1 |
| Two Hundred Day Average | 9.8355 |
| Two Hundred Day Average Change | -0.08549976 |
| Two Hundred Day Average Change Percent | -0.008692976 |
| Type Disp | Equity |
| Volume | 6,233,266 |
| Website | https://www.haleon.com |
| Zip | KT13 0NY |